Luis Palomera Bernal

9PUBLICATIONS
122CO-AUTHORS
Haematological tumoursGene and molecular therapyMedical mycologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 16, 2025
Tafasitamab plus lenalidomide as salvage therapy in diffuse large B-cell lymphoma: real-world experience from GELTAMO.

Antonio Gutierrez, Izaskun Zeberio, Francisco Javier Peñalver

|Jun 11, 2025
High-dose busulfan-melphalan vs melphalan and reinforced VRD for newly diagnosed multiple myeloma: a phase 3 GEM trial.

Juan José Lahuerta, Jesús San-Miguel, Ana Jiménez-Ubieto

|May 22, 2025
Ultrasensitive detection of circulating multiple myeloma cells by next-generation flow after immunomagnetic enrichment.

Marta Lasa, Carmen Gonzalez, Laura Notarfranchi

|Apr 15, 2025
Dynamics of Mutant Hematopoietic Progenitor Cells Are Not Associated with Clinical Outcomes in Multiple Myeloma.

Camila Guerrero, Maria-Jose Larrayoz, Irache Erdozain

|Oct 01, 2024
Minimally Invasive Assessment of Peripheral Residual Disease During Maintenance or Observation in Transplant-Eligible Patients With Multiple Myeloma.

Marta Lasa, Laura Notarfranchi, Cristina Agullo

|Sep 18, 2024
Measurable residual disease by mass spectrometry and next-generation flow to assess treatment response in myeloma.

Noemí Puig, Cristina Agulló, Teresa Contreras

Pageof 2

Frequent Collaborators

8 joint publications

Albert Oriol

8 joint publications

Noemi Puig

8 joint publications

Bruno Paiva

8 joint publications

Jesus San-Miguel